Combinatorial therapy of imipridones and histone deacetylase inhibitors in Ewing sarcoma cell lines demonstrates synergistic cell death.

被引：0
|
作者：
Chang, Wen-i [1 ]
Zhou, Lanlan [1 ]
Seyhan, Attila [1 ]
Prabhu, Varun V. [2 ]
El-Deiry, Wafik S. [1 ]
机构：
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Oncoceut Inc, Philadelphia, PA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1060
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines
    Emionite, L
    Galmozzi, F
    Grattarola, M
    Boccardo, F
    Vergani, L
    Toma, S
    ANTICANCER RESEARCH, 2004, 24 (06) : 4019 - 4024
  • [32] Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines
    Gray, SG
    Qian, CN
    Furge, K
    Guo, X
    Teh, BT
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (04) : 773 - 795
  • [33] Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines
    Kisseberth, William C.
    Murahari, Sridhar
    London, Cheryl A.
    Kulp, Samuel K.
    Chen, Ching-Shih
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2008, 69 (07) : 938 - 945
  • [34] Radiosensitization by histone deacetylase inhibitors +/- demethylating agents in head and neck cancer cell lines
    De Schuller, H.
    Van Criekinge, W.
    Nuyts, S.
    EJC SUPPLEMENTS, 2007, 5 (08): : 23 - 23
  • [35] Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines
    Sakajiri, S
    Kumagai, T
    Kawamata, N
    Saitoh, T
    Said, JW
    Koeffler, HP
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (01) : 53 - 61
  • [36] Histone deacetylase inhibitors reverse EMI phenotype and chemoresistance in pancreatic cancer cell lines
    Fournier, Keith
    Choi, Woonyoung
    Maarquis, Lauren
    McConkey, David J.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] Inhibition of poly ADP ribose polymerase (PARP) induces cell death in leukaemic cell lines alone or synergistically with histone deacetylase inhibitors: potential for anti-leukaemia therapy
    Gaymes, T. J.
    Shall, S.
    Farzaneh, F.
    Mufti, G. J.
    LEUKEMIA RESEARCH, 2007, 31 : S61 - S62
  • [38] A mechanistic approach to anticancer therapy: Targeting the cell cycle with histone deacetylase inhibitors
    Mork, CN
    Faller, DV
    Spanjaard, RA
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1091 - 1104
  • [39] Synergistic Activity of Histone Deacetylase and Proteasome Inhibition Against Pancreatic and Hepatocellular Cancer Cell Lines
    Spratlin, J. L.
    Pitts, T. M.
    Kulikowski, G. N.
    Morelli, M. P.
    Tentler, J. J.
    Serkova, N. J.
    Eckhardt, S. G.
    ANTICANCER RESEARCH, 2011, 31 (04) : 1093 - 1103
  • [40] Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells
    Kumar, K. Saravana
    Sonnemann, Juergen
    Beck, James F.
    ONCOLOGY REPORTS, 2006, 16 (05) : 1047 - 1052
12345